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Abstract 
A novel Affimer-functionalised interdigitated electrode-based capacitive biosensor platform 
was developed for detection and estimation of Her4, a protein tumour biomarker, in undiluted 
serum. An anti-Her4 Affimer with a C-terminal cysteine was used to create the bio-recognition 
layer via self-assembly on gold interdigitated electrodes for the sensor fabrication. Electrochemical 
impedance spectroscopy (EIS) in the absence of redox markers was used to evaluate the sensor 
performance by monitoring the changes in capacitance. The Affimer sensor in buffer and in 
undiluted serum demonstrated high sensitivity with a broad dynamic range from 1 pM to 100 nM 
and a limit of detection lower than 1 pM both in buffer and in serum. Furthermore, the Affimer 
sensor demonstrated excellent specificity with negligible interference from serum proteins, 
suggesting resilience to non-specific binding. The sensing ability of the present Affimer sensor in 
spiked undiluted serum suggests its potential for a new range of Affimer-based sensors. The 
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fabricated Affimer sensor can thus be further adapted with other probes having affinities to other 
biomarkers for a new range of biosensors. 
Keywords: Affimer; impedimetric; capacitance; biosensor; serum; Her4 
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1. Introduction. 
In recent years, the development of novel bioreceptors has rapidly expanded. The primary 
motivations behind these developments for the biochemists / molecular biologists have been not 
only the large biological potential but also an enormous demand for synthetic bio-receptors Whilst 
antibodies remain the workhorse choice for the molecular recognition for many biosensing devices 
and laboratory assays, their usage can still impose limitations on technology adoption, in particular 
due to their large size, multi domain protein structure with unstable disulphide bond, instability 
during regeneration, unpredictable interaction with target, along with difficulty in production and 
high cost (Raina et al. 2015; Song et al. 2008; Vazquez-Lombardi et al. 2015). One long-
championed alternative to antibodies has been DNA aptamers, which are single stranded 
oligonucleotide sequences possessing high affinity and specificity for its desired target. DNA 
aptamers, in their own right, have been extensively used for biosensing applications (µaptasensors¶), 
yet the approach has had little impact as a viable bioanalytical tool to date (Rimmele 2003; Xu et al. 
2009). Despite many advantages over antibodies, they still possess a number of limitations, for 
example, degradation by nucleases (DNAse and RNAse) or protein fouling in serum due to DNA 
binding proteins (Keum and Bermudez 2009; Sylvia et al. 1975).  
A new emerging class of bioreceptors inspired from the increasing understanding of 
antibodies are Affimers®, generically termed as peptide aptamers (Tiede et al. 2017; Woodman et 
al. 2005). Based on their scaffold origin from human stefin A protein or consensus plant 
phytocystatin protein, Affimers are classified as type I and type II (Tiede et al. 2014) with both 
types containing DQ Į-helix and IRXU ȕ-sheets (Bedford et al. 2017). Affimers are small receptor 
non-antibody proteins (Mw ~ 15 kDa, size 2-4 nm) mainly containing two 9 amino acids variable 
regions for molecular recognition and function as a protein platform for the restriction of two 
variable recognition peptide regions (Bedford et al. 2017; Johnson et al. 2012; Raina et al. 2015; 
Straw et al. 2013; Tiede et al. 2014; Tiede et al. 2017; Woodman et al. 2005). Furthermore, 
Affimers mimic the molecular recognition characteristic of monoclonal antibodies for the detection 
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of biomolecules. Unlike antibodies, Affimers display robust characteristics of low molecular weight, 
high thermostability, and resistance to extreme pH conditions, ease of site specific 
functionalization, low production cost with high reproducibly using E. coli recombinant protein 
expression systems (Arrata et al. 2017; Bedford et al. 2017; Koutsoumpeli et al. 2017; Kyle et al. 
2015; Raina et al. 2015; Rawlings et al. 2015; Tiede et al. 2014; Vazquez-Lombardi et al. 2015; 
Wang et al. 2017b). Of key relevance, there is recent work demonstrating the application of 
Affimers for biosensing applications (Estrela et al. 2010; Ko Ferrigno 2016; Koutsoumpeli et al. 
2017; Raina et al. 2015; Sharma et al. 2016; Wang et al. 2017b).  
This study aims to develop for the first time an Affimer-based electrochemical sensor 
targeting Her4. Her4 belongs to the HER (human epidermal growth factor receptor related) family, 
which includes four transmembrane receptors tyrosine kinase (RTKs) named EGFR: Her1 (ErbB1), 
Her2 (ErbB2), Her3 (ErbB3) and Her4 (ErbB4) (Tebbutt et al. 2013). The altered expression of the 
HER family have been implicated in many human diseases and has been proposed as a potential 
prognostic and diagnostic biomarker (Zhao et al. 2014). Her4, for example, is a ~70 kDa protein 
and an emerging biomarker for the detection of gastrointestinal stromal tumours, which accounts for 
more than 80% of all gastrointestinal mesenchymal tumours and is the most common type of 
gastrointestinal tumours with increased incidence rate (Mucciarini et al. 2007; Nilsson et al. 2005; 
Sandvik et al. 2011; Steigen and Eide, 2009). In addition, the Her4 ectodomain has been detected at 
low concentrations in the serum of breast cancer patients and could potentially serve as a prognostic 
or predictive marker as part of a profile with other biomarkers (Hollmén et al. 2012; Olsen et al. 
2009).  
Recently the use of electrochemical biosensors for biomarker detection has gained much 
attention. Among various biosensors, electrochemical impedance spectroscopy (EIS)-based sensing 
for probing the features of surface-modified electrodes has recently gained particular attention for 
label free, fast, sensitive and miniaturized biosensor development (Arya et al. 2014; Arya et al. 
2018; Gong et al. 2017; Sharma et al. 2016). An EIS measurement uses a small amplitude 
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perturbing sinusoidal alternative voltage signal applied during scanning over a wide range of 
frequencies in an electrochemical cell to measure the resulting AC current response. EIS exploits 
resistive and capacitive properties of material for analysis. Using proper equivalent circuit models, 
EIS can be utilized for the characterization, analysis and study of coatings, fuel cells batteries, 
corrosion phenomena, electrode kinetics, conducting polymers, semiconductors, sensors, animal 
and plant tissues and general material (Guan et al. 2004; Katz and Willner 2003). EIS-based 
biosensors measure changes in impedance or capacitance that occur at an electrode surface upon 
target binding and can be utilized for wide concentration range estimation (Ramón-Azcón et al. 
2008). Using EIS researchers have reported measurement of various small and large size targets 
such as cortisol in saliva, epidermal growth factor receptor (EGFR), cardiac troponin I, tau protein, 
C-reactive protein in blood, insulin in blood serum, etc in wide concentration ranges from low 
picomolar to high nanomolar (Bryan et al. 2013; Pasha et al. 2014; Vasudev et al. 2013; Wang et al. 
2016; Wang et al. 2017a; Xu et al. 2013). In these and other reports researchers have shown 
sensitive measurements of targets in real samples using EIS either directly or after washing the 
electrode. Furthermore, recently it has been shown that the development of EIS-based biosensor 
using interdigitated microelectrodes (IDµEs) can provide added advantages of superior sensitivity, 
faster steady state, better reaction kinetics, and better signal-to-noise ratio (Arya and Bhansali 2012; 
Ramón-Azcón et al. 2008; Varshney and Li 2009). Also, EIS-based biosensor development 
provides options of measurement of impedance/charge transfer resistance in Faradaic mode using 
redox markers in solution (Arya et al. 2014; Santos et al. 2014) or capacitance in non-Faradaic 
mode without any redox markers (Berggren et al. 2001; Luo and Davis 2013; Qureshi et al. 2010) 
for highly sensitive detection of analytes. Non-Faradaic approaches do not require the presence of 
redox probes in the analytical solution; they measure capacitive changes occurring due to bio 
recognition causing charge distribution, surface dielectric properties or local conductance variations 
via water molecules displacement and ions movement away from the surface during molecular 
interactions. In non-Faradaic mode, no redox probes need to be to introduced to the sample to be 
  6 
measured; hence it is a method with direct applicability for point-of-care diagnostics (Arya et al. 
2018; Berggren et al. 2001; Luo and Davis 2013; Qureshi et al. 2010). 
This study aims to utilize the advantage of Affimer combined with non-Faradaic impedance 
and ,'ȝ( to develop, for the first time, an Affimer-based electrochemical biosensor for Her4 
detection in undiluted serum. )RUELRVHQVRUGHYHORSPHQWJROG,'ȝ(FKLSVZHUHIXQFWLRQDOL]HGZLWK
cysteine modified Her4 Affimer via self-assembly and used for specific capture of Her4 protein. 
The surface was further blocked using phosphate buffer saline-tween 20 based starting block (SB) 
to prevent non-specific binding and fouling of the surface. Non-Faradaic electrochemical 
impedance spectroscopy was utilized to quantify Her4 binding events in buffer and serum samples 
by monitoring the changes in capacitance. The fabricated Affimer biosensor demonstrated excellent 
sensitivity and a wide dynamic range from 1 pM to 100 nM in both buffer and spiked undiluted 
human serum samples. When challenged with other serum proteins, the Affimer exhibited excellent 
specificity towards Her4. The present Affimer biosensor exhibits with its low background and broad 
linear response range, will pave the way to new platforms for alternative low cost and rapid 
multiplexed biosensors. 
 
2. Experimental 
2.1. Reagents 
Cysteine terminated Affimer binders to Her4 have previously been characterised in affinity 
staining cells and in super-resolution microscopy (Tiede et al. 2017). The Affimer demonstrated 
excellent specificity for imaging of fixed cell and single-particle tracking on live cells. For binding 
studies, different concentrations of Her4 and control molecules were prepared in 10 mM phosphate 
buffer saline (PBS), pH 7.4 or in undiluted serum. PBS-Tween20 (PBST20) based starting block 
(SB) was procured from Fisher Scientific (UK); 'XOEHFFR¶V 3KRVSKDWH %XIIHUHG 6DOLQH DQG
Phosphate Buffered Saline with 0.05% Tween20 was procured from Sigma (UK). For serum 
spiking studies to mimic clinical samples, human serum, from human male AB was procured from 
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Sigma. All other chemicals were of analytical grade and were used without further purification. All 
aqueous solutions were prepared using 18.2 0ȍ
 
cm ultra-pure water with a Pyrogard® filter 
(Millipore, MA, USA). 
 
2.2. Apparatus 
Biosensor fabrication was characterised using electrochemical impedance spectroscopy (EIS) 
in a three-electrode configuration with gold as counter and pseudo reference electrode at 
equilibrium potential (open circuit potential generated between electrodes dipped in electrolyte), 
without external biasing in the frequency range of 100 kHz - 100 mHz, with a 25 mV amplitude 
using a using a µAutolab III / FRA2 potentiostat/galvanostat (Metrohm, Netherlands). EIS 
measurements were carried out using 50 ȝL of PBS solution (10 mM, pH 7.4) containing a mixture 
of 5 mM Fe(CN)64í (ferrocyanide) and 5 mM of Fe(CN)63í (ferricyanide) as a redox probe. For 
Her4 detection and estimation, non-Faradaic EIS measurements (absence of redox couple) were 
performed in a two interdigitated electrodes configuration in 10 mM PBS (pH7.4) in a frequency 
range 100 kHz - 100 mHz, with a 200 mV amplitude.  
Surface characterisation of gold electrodes modified with Affimer was performed using EIS, 
surface plasmon resonance (SPR), contact angle and atomic force microscopy (AFM). Ambient 
contact mode (tapping mode) AFM imaging was performed using MultiMode NanoScope with IIIa 
controller (Bruker, Germany) in conjunction with version 6 control software. Gold chips modified 
as described in the fabrication section for gold electrodes were imaged with a 10 nm diameter AFM 
ContAl-G tip (BudgetSensors®, Bulgaria), images were then processed by the NanoScope Analysis 
software, version 1.5. Contact angle measurements were performed using an in-house built optical 
angle measurement system (Miodek et al. 2015). The electrodes were placed on the stage and a 5 
µL drop was dispensed on the electrode with the dispensing system. The wetting of surface was 
then captured using a Nikon p520 camera. Contact angle was measured using a screen protractor 
version 4.0 procured from Iconico. SPR measurements were performed using a Reichert SPR 
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7000DC (USA) dual channel flow spectrometer at 25 °C. 50 nm gold coated SPR gold chips, 
supplied from Reichert Technologies were used for studying the reaction on SPR. Prior to their 
modification, the chips were cleaned using piranha solution (3:1 H2SO4:H2O2) for 20 seconds and 
rinsed thoroughly with MilliQ water and dried using nitrogen gas. All buffers were filtered through 
0.2 µm filters and degassed for 2 h by sonication prior to the experiment.  
 
2.3. Electrode preparation and functionalisation 
2.3.1 Gold electrode fabrication 
Gold interdigitated micro-electrode arrays (IDµE) on silicon/silicon oxide wafers were 
created using lithographic and micro-fabrication techniques as described in an earlier report (Pui et 
al. 2013). In brief, Ti/Au (15 nm/200 nm) IDµE having fingers of 5 µm width and 3200 µm length, 
spaced at 10 µm and spread over a 5500 µm length were deposited on silicon/silicon oxide wafers 
using standard photolithography techniques. IDµE, reference and counter electrodes were patterned 
via photoresist spin coating followed by photolithography through a chrome mask and 
development. After the metal deposition an electron-beam evaporator, etching of unpatterned metal 
regions with Au etchant and Ti etchant was performed. Photoresist was then stripped in solvent 
followed by wafer cleaning and dicing. The schematics in Figure 1 summarize the electrode 
fabrication process along with an optical image of the chip showing the IDµE section. 
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Figure 1. (a-e) Electrode fabrication process; (f) Optical image of chip showing IDµE section; 
(g) Schematic for Affimer sensor preparation and Her4 capture. 
 
2.3.2 Gold electrode functionalization with Affimer 
Prior to functionalisation, electrodes were pre-cleaned thoroughly with isopropyl alcohol, 
acetone and de-ionised milli-Q water (Millipore, UK), followed by 30 min treatment using UV-
ozone (ProCleaner, BioForce Nanosciences, USA). For Affimer self-assembled monolayer (SAM) 
formation conditions were optimized and using optimized conditions 100 µg/mL solution of cys-
(a) SiO2/Si
(b) Photoresist
(c) Patterning
(d) deposition
(e) lift-off
20 µm
(f) Optical image
Affimer
Blocking buffer
Her4
(g) 
  10 
Her4 Affimer containing 5 mM Tris (2-carboxyehyl) phosphine hydrochloride (TCEP) was 
prepared in 10 mM PBS buffer (pH 7.4) and incubated for 30 min at 37 °C to reduce any di-
sulphide bonds. After reduction, 50 µL of this mixture was poured onto the IDµE electrodes and 
incubated for 120 min at 37 °C. Thereafter, the chips were washed with PBST20 (10 mM, pH 7.4) 
and PBS (10 mM, pH 7.4) to remove any unbound Affimer. The chips were finally blocked with SB 
for 30 min and after removing extra solution, chips were stored at 4 ºC till further use. Figure 1g 
shows the schematic for Affimer sensor electrode preparation. 
 
3. Results and Discussion 
3.1. Characterisation of the Affimer sensor fabrication 
3.1.1 Contact angle and atomic force microscopic characterisation  
Contact angle and atomic force microscopy (AFM) were used to determine the efficiency of 
the Affimer immobilization onto the electrode surface. The effect of Affimer monolayer formation 
on the surface's hydrophilic/hydrophobic properties was estimated using contact angle images 
recorded on gold chips without any pattern. To measure contact angle, electrodes without and with 
Affimer monolayer were placed on the stage and a 5 µL of ultra-pure water drop was dispensed on 
the electrode. From Figure 2a, it is clear that clean gold showed a hydrophilic character with a 
contact angle value of 23º. After Affimer monolayer formation, the contact angle was found to 
increase to 44º (Figure 2b), confirming the immobilization of the Affimer. Increasing contact angle 
indicates a more hydrophobic character of the Affimer electrode as compared to gold. On the AFM 
studies, the images of blank gold and Affimer-modified gold surface presented in Figure 3 further 
confirm the Affimer binding. The Affimer modified surface showed more uniformed morphology 
when compared with blank.  
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Figure 2. Contact angle images for (a) blank cleaned gold surface and (b) after Affimer SAM 
formation. 
 
 
Figure 3. AFM images for (a) blank cleaned gold surface and (b) after Affimer SAM formation. 
 
3.1.2. Electrochemical impedance spectroscopy and surface plasmon resonance characterisation 
Faradaic-mode electrochemical impedance spectroscopy was utilised to further determine 
whether the Affimer has been immobilised on the surface (see Nyquist plots in Figure 4a). The plots 
follow a standard Randles equivalent circuit, as shown in Figure 4b (i), with the capacitance 
replaced by a constant phase element. After Affimer immobilization, the low frequency Warburg 
element is no longer observed and the plot resembles the equivalent circuit in Figure 4b (ii). The 
observed tail in low frequency region due to Warburg impedance in blank electrode spectra indicate 
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high conductivity of blank electrode, thus causing charge diffusion at lower frequency region. 
Whereas after Affimer binding surface become insulating due to immobilization of insulating 
protein of the surface, thus allowing no free diffusion of charge in lower frequency region and 
following circuit (ii). A change in charge transfer resistance (Rct) value from 680 ȍ for blank to 
50.7 Nȍ for the Affimer SAM and blocker modified sensor surface shows the immobilisation of 
Affimer in high density forming SAM (Figure 4a). The large change in Rct can be attributed to the 
insulating nature and dense immobilisation of pre-reduced Affimer solution onto the gold surface. 
For the observed high Rct and assuming the measured current is mainly due to defects in the 
monolayer, the surface coverage was estimated using T
 
=
 
1
 
-
 
Rct/Rct0, where Rct and Rct0 indicate the 
charge transfer resistance before and after monolayer formation, and found to be 98.66% coverage. 
It should be noted that high density immobilization of the capture molecules may not always result 
in better analyte capture probabilities and steric crowding effects of tightly packed receptor 
molecules may actually degrade the sensor performance (Bonanno and DeLouise 2007). To study 
this effect for Her4 Affimer, Affimer monolayer formation during optimization was also tested 
without pre-reduction and much lower impedance for immobilization was observed indicating 
porous film, however negligible response was observed in capacitive sensing for Her4 indicated 
necessary pre-reduction. Thus, pre-reduction was optimized and the best response was observed 
with Affimer monolayer formation after pre-reduction done via 30 min incubation of Affimer-
TCEP mixture at 37 °C to reduce any disulphide bonds. A very small change in impedance is 
observed after the blocking step, further suggesting the dense coverage by Affimer, which leave 
very few free spaces on the surface to be taken up by blocker protein molecules.  
To confirm the immobilization and ability of surface attached Affimer molecules to capture 
Her4 molecules, SPR spectra was recorded. For SPR studies, gold chips were modified using the 
same procedure as that used for IDµE modification. The modified SPR chips were then utilised to 
investigate Her4 capture in PBST20, i.e. in the same buffer as used for the impedance sensor. In 
Figure 4c increase in SPR signal after introduction of Affimer solution and a large change in the 
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signal indicate successful binding of Affimer. Further an increasing SPR signal for increasing Her4 
concentration in Figure 4d, confirms the activity of Affimer molecules bound on surface, in 
particular above ~100 pM of Her4. 
          
 
Figure 4. (a) Nyquist plots for (i) blank IDµE, (ii) Affimer/IDµE and (iii) blocker/Affimer/IDµE. 
(b) Equivalent circuits used for EIS fitting. (c) Real time SPR spectra for Affimer immobilization. 
(d) Real time SPR response for (i) PBST20, (ii) 100 pM Her4 in PBST20, (iii) 10 nM Her4 in 
PBST20 and (iv) 100 nM Her4 in PBST20 using Affimer sensor. 
 
3.2. Her4 studies  
3.2.1 Capacitive measurement via electrochemical impedance for Her4 in PBS 
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The SB/Affimer/IDµE based sensors were used to investigate the interaction between surface 
bound Affimer and Her4 concentrations from 1 pM to 100 nM (Figure 5). For measurement of each 
concentration, the bio-electrode was incubated with a Her4 solution for 30 min, followed by 
PBST20 and PBS washing. Non-Faradaic EIS spectra was then recorded on washed electrode using 
PBS (10 mM, pH 7.4) and the obtained data was converted to capacitance values using C = -1/ȦZ'', 
where C is the capacitance, Z the DQJXODUIUHTXHQF\DQG=´ the imaginary part of the impedance. 
From the capacitance curves (Figure 5b), values were noted at 3 Hz, where a maximum in phase 
angle is observed (Figure 5a), corresponding to a maximum capacitive effect. The values were then 
plotted for different concentrations of Her4 for calibration curve (Figure 5c). It is clear from Figure 
5c that the capacitance decreases linearly in a log scale with increasing Her4 concentration, which 
can be attributed to the binding of Her4 proteins to surface bound Affimer. Furthermore, such 
decrease in capacitance after Her4 binding may be attributed to variations in charge distribution, 
surface dielectric properties or local conductance via water molecules displacement and ions 
movement away from the surface during Her4 interaction with surface bound Affimer molecules 
(Arya et al. 2018; Berggren et al. 2001; Luo and Davis 2013). The electrodes can thus be used for 
Her4 sensing in the 1 pM to 100 nM range and can be characterised using the relationship for the 
change in capacitance -ǻC (µF) = 0.07 + 0.03 log CHer4 (CHer4 is the concentration of Her4 in pM). 
The Affimer sensor thus exhibits a sensitivity of 0.03 µF/log CHer4 with a correlation coefficient of 
0.996 and a limit of detection lower than 1 pM. For relative changes, results of different electrodes 
were found to fall within a 4% error range as indicated by error bars in Figure 5c.  
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Figure 5. (a) EIS phase angle vs. frequency; (b) capacitance data for interaction between surface 
bound Affimer with Her4 concentrations in PBS; (c) calibration curve using capacitance data for 
different concentrations at 3 Hz. 
 
3.2.2 Capacitive measurement via electrochemical impedance for Her4 in undiluted serum 
To validate the electrode for real clinical applications, Affimer sensor electrodes were tested 
with undiluted serum spiked with Her4 to investigate the interaction between surface bound 
Affimer and Her4 molecules (1 pM to 100 nM) in presence of all types of serum proteins (Figure 
6). Bioassay and measurements were carried out in same manner as done for PBS. Similarly, non-
Faradaic EIS data was converted to capacitance and using capacitance curves (Figure 6b); 
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capacitance values were noted at 1 Hz, where the maximum phase angle is observed (Figure 6a 
inset). The slight shift in the frequency for which a maximum phase occurs may be attributed to the 
presence of different types of serum proteins and to different conductivity and ionic strength of the 
serum compared to PBS. The capacitance values were then plotted for different concentrations of 
Her4 for the calibration curve presented in Figure 6c. It is clear from Figure 6b that undiluted serum 
in absence of Her4 shows negligible effects at 1 Hz and a decrease in capacitance was observed 
only in the presence of Her4 in serum, indicating selective and successful interaction between Her4 
proteins and surface bound Affimer. Again, for sensing application, the relative change in 
capacitance data was estimated and utilised for more significant information. It is clear from Figure 
6c that the capacitance decreases linearly in a log scale with increasing Her4 concentration in 
serum, which can be attributed to the binding of Her4 proteins to surface bound Affimer. Figure 6c 
shows that the electrodes can be used for Her4 sensing in the 1 pM to 100 nM range following the 
relationship -ǻC (µF) = 0.095 + 0.049 log CHer4 (pM). Affimer sensor electrodes thus exhibit a 
sensitivity of 0.049 µF/log CHer4 with a correlation coefficient of 0.978 and a limit of detection 
below 1 pM. Results for different electrodes were found to fall within a 5% error range as indicated 
by the error bars in Figure 6c.  
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Figure 6. (a) EIS phase angle vs. frequency; (b) capacitance data for interaction between surface 
bound Affimer with Her4 concentrations in undiluted serum; (c) calibration curve using capacitance 
data for different concentration at 1 Hz. 
 
Comparison of Figure 5 and 6 reveals that the background signal (in the absence of Her4) is 
similar, suggesting no or negligible non-specific binding of serum proteins to the Affimer sensor. 
However; for any given concentration of Her4, the signal for Her4 (change in capacitance from 
blank value) was found to be larger in serum than in buffer (compare Figure 5 and 6). The change in 
capacitance may be attributed to specific binding effect of the Her4 and exact reason for larger 
change during measurement in serum is not clear at present, however it may be attributed to one or 
more potential explanations. First, this increase might be attributed to a better folding of Her4 in 
serum than in buffer, leading to more productive interactions between molecules of Her4 and the 
Affimer. A similar effect has also been observed by Park et al. (2002) for measuring Nicotinamide 
phosphoribosyl transferase via aptamer-based capacitive sensing. Second, the increase could be due 
to the effect of proteins bound to Her4 that are recruited to the surface through the interaction of 
Her4 with the Affimer. Further, the slight deviation from linearity for the measurements in the 
presence of serum may also be attributed to the second explanations. Affimer sensor electrodes 
were also tested for serum spiked with the control proteins prostate specific antigen and thrombin 
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and found to result in insignificant effect on signal, suggesting specificity of sensor and again 
consistent with the idea that the increased signals for Her4 measured in serum compared to buffer is 
due to specific effects of Her4 and/or Her4-associated serum proteins with the Affimer sensor.  
 
4. Conclusions 
In conclusion, a new Affimer-based alternative strategy has been demonstrated for the 
detection of Her4 protein biomarker in undiluted serum. The Affimer-based sensor shows slightly 
better sensitivity as compared to antibody-based assays available commercially (LifeSpan 
BioSciences) but with a must larger dynamic range (1-70 pM for the ELISA kit), faster response 
time, ease of use and lower cost. The Affimer sensor also showed excellent selectivity when 
challenged with other serum protein. The prepared electrodes showed high sensitivity of 
0.049 µF/ log CHer4 in undiluted serum with a detection limit lower than 1 pM. The biosensor shows 
good selective measurement of Her4 in undiluted serum in concentration range of 1pM ± 100 nM, 
with very low non-specific response to serum proteins.  
To date only a handful of reports in the literature have described the detection of Her4 in 
serum so it is as yet unknown whether serum-resident Her4 represents a useful biomarker in cancer 
or other diseases. However, the Affimer sensor, with its low background and broad linear response 
range, will enable progress in this field. Furthermore, the fabrication method is simple and can be 
applied for the detection of other biomarkers in serum samples, paving the way to new platforms for 
alternative low cost and rapid multiplexed biosensors. 
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